Dyslipidemia and diabetes: a personal view.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
B R Zimmerman

Abstract

Cardiovascular disease, the main cause of morbidity and mortality in patients with diabetes, justifies an aggressive approach to the reduction of modifiable risk factors. Lipid values are generally normal in patients with insulin-dependent diabetes mellitus, but hypertriglyceridemia and low levels of high-density lipoprotein (HDL) cholesterol are frequently associated with non-insulin-dependent diabetes mellitus (NIDDM). Recommendations for screening and treatment of patients without diabetes do not apply to those with NIDDM. Screening should be done annually and should include fasting total cholesterol, triglycerides, and HDL cholesterol. Therapeutic recommendations based solely on the low-density lipoprotein cholesterol level are inappropriate. Hypertriglyceridemia cannot be ignored in patients with NIDDM. Therapy should first be directed toward improved control of the diabetes through diet, exercise, and insulin or sulfonylureas. Therapeutic goals are selected on the basis of individual risk assessment and are strongly influenced by the presence of preexisting vascular disease. When the goals are not achieved through improved control of diabetes, lipid-lowering drug therapy, based on the specific profile of the lipid abnorma...Continue Reading

References

Oct 18, 1990·The New England Journal of Medicine·J E RossouwB M Rifkind
Aug 5, 1988·JAMA : the Journal of the American Medical Association·V ManninenP Koskinen
Aug 1, 1987·The American Journal of Medicine·J R Crouse
Aug 15, 1994·Annals of Internal Medicine·D R GrayM L Kashyap
Nov 1, 1994·Annals of Internal Medicine·B KinosianG Garland
Mar 1, 1994·Diabetes Care·L V CampbellL H Storlien
Jun 15, 1994·Annals of Internal Medicine·C C Walden, R A Hegele
Oct 1, 1993·Diabetes Care
Feb 1, 1993·Diabetes Care·E ManzatoD Fedele

❮ Previous
Next ❯

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.